Informações:
Falhas:
ID
34393
Descrição
A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status; ODM derived from: https://clinicaltrials.gov/show/NCT01283386
Link
https://clinicaltrials.gov/show/NCT01283386
Palavras-chave
Versões (1)
- 17/01/2019 17/01/2019 -
Titular dos direitos
GSK group of companies
Transferido a
17 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Similar models
Eligibility Lymphocytic Leukemia, Chronic NCT01283386
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
adult patients, 60-70 or >70 years of age
boolean
ID.2
Item
cumulative illness rating scale (cirs) comorbidity score >/=7 if patient is 60-70 years old
boolean
ID.3
Item
previously untreated b-cell chronic lymphocytic leukemia
boolean
ID.4
Item
binet stage b, c or a with progression
boolean
ID.5
Item
ecog performance status 0-2
boolean
ID.6
Item
small-cell lymphoma
boolean
ID.7
Item
autoimmune hemolytic anemia
boolean
ID.8
Item
concomitant malignant disease during enrollment, except for basal cell carcinoma of the skin
boolean
ID.9
Item
chemotherapy for concomitant malignant disease within 12 months prior to study enrollment
boolean
ID.10
Item
richter's syndrome
boolean